NASDAQ:EQ

Equillium Stock Predictions

etoro logo Buy EQ
*Your capital is at risk
$3.11
+0.320 (+11.47%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

EQ Prediction Chart

EQ Predictions History

Latest community submissions for EQ.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 24, 2026 $2.25 +3.75% $2.16 X 95.77% 0
Apr 24, 2026 $2.09 -3.75% $2.16 V 96.70% 1
Apr 24, 2026 $2.12 -2.34% $2.16 V 98.11% 1
Apr 24, 2026 Bullish $2.16 X 0
Mar 25, 2026 $2.03 +4.29% $2.06 V 98.72% 2
Mar 25, 2026 $2.00 +2.68% $2.06 V 97.20% 1
Mar 25, 2026 $1.99 +2.05% $2.06 V 96.60% 1
Feb 17, 2026 $1.52 -3.16% $1.59 X 95.62% 0
Feb 17, 2026 $1.54 -1.98% $1.59 X 96.79% 0
Feb 17, 2026 $1.69 +7.64% $1.59 V 93.71% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for EQ with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT EQUILLIUM INC.
Equillium
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE